Alpha 2.0
Login Register
» Articles » PMID: 30882331

Combination of Clindamycin and Azithromycin As Alternative Treatment for Toxoplasma Gondii Encephalitis

Overview
Journal Emerg Infect Dis
Specialty Infectious Diseases
Date 2019 Mar 19
PMID 30882331
Citations 12
Authors
Daisuke Shiojiri
Ei Kinai
Katsuji Teruya
Yoshimi Kikuchi
Shinichi Oka
Affiliations
Soon will be listed here.
Abstract

Current standard therapies for toxoplasmic encephalitis often cause severe adverse events. A 57-year-old HIV-positive man in Japan who had toxoplasmic encephalitis but was intolerant to trimethoprim/sulfamethoxazole, pyrimethamine, sulfadiazine, and atovaquone was successfully treated with the combination of clindamycin and azithromycin. This drug combination can be an alternative treatment for this condition.

Citing Articles

Apigeninidin chloride disrupts Mitochondrial membrane potential and induce reactive oxygen species and metabolites production.

Moon M, Kamasah J, Sharma H, Robertson B, Abugri D Front Cell Infect Microbiol. 2024; 14:1368019.

PMID: 39588510 PMC: 11586383. DOI: 10.3389/fcimb.2024.1368019.

The use of azithromycin and pyrimethamine for treatment of cerebral toxoplasmosis in human immunodeficiency virus-infected patients: a systematic review.

Ramos M, Villaraza S Encephalitis. 2023; 3(2):64-70.

PMID: 37469675 PMC: 10295825. DOI: 10.47936/encephalitis.2022.00115.

Anti-Toxoplasma gondii activity of Trametes versicolor (Turkey tail) mushroom extract.

Sharma H, Catrett J, Nwokeocha O, Boersma M, Miller M, Napier A Sci Rep. 2023; 13(1):8667.

PMID: 37248277 PMC: 10225767. DOI: 10.1038/s41598-023-35676-6.

A Metabolomic and Transcriptomic Study Revealed the Mechanisms of Lumefantrine Inhibition of .

Li M, Sang X, Zhang X, Li X, Feng Y, Yang N Int J Mol Sci. 2023; 24(5).

PMID: 36902335 PMC: 10003460. DOI: 10.3390/ijms24054902.

Unveiling of brain transcriptome of masked palm civet (Paguma larvata) with chronic infection of Toxoplasma gondii.

Yuan H, Zhang X, Yang Z, Wang X, Mahmmod Y, Zhang P Parasit Vectors. 2022; 15(1):263.

PMID: 35871661 PMC: 9308931. DOI: 10.1186/s13071-022-05378-5.

References
1.
Hernandez A, Thota P, Pellegrino D, Pasupuleti V, Benites-Zapata V, Deshpande A . A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?. HIV Med. 2016; 18(2):115-124. DOI: 10.1111/hiv.12402. View
2.
Neville A, Zach S, Wang X, Larson J, Judge A, Davis L . Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity. Antimicrob Agents Chemother. 2015; 59(12):7161-9. PMC: 4649158. DOI: 10.1128/AAC.02009-15. View
3.
Katlama C, de Wit S, ODoherty E, Van Glabeke M, Clumeck N . Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis. 1996; 22(2):268-75. DOI: 10.1093/clinids/22.2.268. View
4.
Fallahi S, Seyyed Tabaei S, Pournia Y, Zebardast N, Kazemi B . Comparison of loop-mediated isothermal amplification (LAMP) and nested-PCR assay targeting the RE and B1 gene for detection of Toxoplasma gondii in blood samples of children with leukaemia. Diagn Microbiol Infect Dis. 2014; 79(3):347-54. DOI: 10.1016/j.diagmicrobio.2014.02.014. View
5.
Katlama C, Mouthon B, Gourdon D, Lapierre D, Rousseau F . Atovaquone as long-term suppressive therapy for toxoplasmic encephalitis in patients with AIDS and multiple drug intolerance. Atovaquone Expanded Access Group. AIDS. 1996; 10(10):1107-12. View